Skip to main content

Day: August 6, 2025

Merus to Present at the Canaccord Genuity 45th Annual Growth Conference

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 at 1:30 p.m. ET. The webcast of the presentation will be contemporaneously available on the Investors page of the Company’s website. The archived presentation will also be available there for a limited time after the event. About MerusMerus is an oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®....

Continue reading

Pure Harvest Corporate Group Eliminates All Debt and Enters New Phase of Strategic Growth

GREENWOOD VILLAGE, Colo., Aug. 06, 2025 (GLOBE NEWSWIRE) — Pure Harvest Corporate Group, Inc. (OTC: PHCG), a diversified holding company focused on acquiring and revitalizing undervalued businesses, is pleased to announce that it has officially eliminated all remaining debt from its balance sheet, marking a major turning point in the Company’s transformation. Following a comprehensive effort to restructure liabilities and strengthen the Company’s financial foundation, Pure Harvest is now debt-free and positioned to accelerate its long-term vision with renewed focus and flexibility. This achievement clears the path for growth initiatives and strategic investments designed to drive lasting value for shareholders. “This is a pivotal moment for Pure Harvest,” said Richard Hawkins, Interim CEO and Chairman of the Company. “We’ve spent...

Continue reading

Holley Reports Second Quarter 2025 Results

SECOND CONSECUTIVE QUARTER OF CORE NET SALES GROWTHSUCCESSFUL TARIFF MITIGATION TO DATE THROUGH STRATEGIC SOURCING AND PRICING Strong first half results driven by continued execution of our 2025 strategic framework. Core business growth improved again in the second quarter. Focused execution on tariff mitigation brings greater guidance visibility. BOWLING GREEN, Ky., Aug. 06, 2025 (GLOBE NEWSWIRE) — Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced financial results for its second quarter ended June 29, 2025. Second Quarter Highlights vs. Prior Year PeriodNet Sales decreased (1.7)% to $166.7 million compared to $169.5 million last yearCore business net sales1 for the second quarter of 2025 grew by 3.9% compared to the second quarter of 2024 after excluding non-core...

Continue reading

Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to imdusiran Dr. Roger Sawhney joins the Arbutus Board of Directors following resignation of Anuj Hasija Dr. Harry Janssen joins the Arbutus Scientific Advisory Board Strong financial position with cash, cash equivalents and marketable securities of $98.1M WARMINSTER, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today reported second quarter 2025 financial results and provided a corporate update. “We delivered a strong quarter, marked by positive quarterly earnings resulting from the conclusion of our Greater China partnership with Qilu,” said Lindsay Androski, President and CEO...

Continue reading

Lexicon Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates

Partnership discussions for pilavapadin remain underway following Phase 2b PROGRESS study results IND-enabling studies of LX9851 for obesity and related disorders on track for completion in 2025 with licensee Novo Nordisk expected to submit IND Enrollment completion for SONATA Phase 3 study in both obstructive and non-obstructive hypertrophic cardiomyopathy (HCM) on target for 2026 Conference call and webcast at 8:30 am ET   THE WOODLANDS, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended June 30, 2025, and provided an update on key corporate milestones and accomplishments.  “We continue to make great strides against the strategy we set forth as an R&D focused company,” said Mike Exton, Ph.D., Lexicon’s chief executive officer...

Continue reading

Inspired Reports Second Quarter 2025 Results

Revenue of $80.3 million, up 7% over prior year, driven primarily by record Interactive revenue, up 45% year-over-year Net Operating Income of $7.9 million, Net Loss of $7.8 million and Adjusted Net Loss of $5.6 million Adjusted EBITDA of $28.4 million, up 15% from last year driven by record Interactive Adjusted EBITDA, up 49% year-over-year Secured five-year partnership with Jenningsbet to supply approximately 570 Vantage terminals Successfully completed comprehensive debt refinancing, issuing £270 million senior secured notes and securing a new £17.8 million revolving credit facilityNEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware and services, today reported financial results for the three-month...

Continue reading

Solo Brands, Inc. Announces Second Quarter 2025 Results

Strategic Foundation Set to Build a Structurally Smaller, Profitable Company: Bottom-line Focus Generates Positive Second Quarter Cash from Operations of nearly $11 million GRAPEVINE, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) — Solo Brands, Inc. (NYSE: SBDS)(1) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, today announced its financial results for the three and six months ended June 30, 2025. “For the second quarter, we are pleased to mark significant milestones, including our debt refinancing, removal of the going concern disclaimer and reinstatement of the trading of our Class A common stock, trading under a new ticker symbol SBDS, on the NYSE. In addition, we are making meaningful strides in our transformation...

Continue reading

FLUENT Corp. Provides Management Update

TAMPA, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a leading national cannabis brand, announces that Robert Beasley has provided notice of his resignation from his positions as Chief Executive Officer and a Director of FLUENT, effective August 8, 2025, in furtherance of his and the Company’s mutual determination that a leadership change is in the best interest of the Company as it advances its strategic priorities. William Smith, Executive Chair of the board of directors of the Company (the “Board”), commented, “On behalf of the Board and the entire Company, I would like to extend our sincere gratitude to Robert for his leadership and dedication during his time with the Company. His contributions have been instrumental in positioning us for future growth and sustainable...

Continue reading

IREN July 2025 Monthly Update

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”) today published its monthly update for July 2025. July HighlightsRecord monthly revenue and hardware profit3 AI Cloud expanded with 2.4k NVIDIA B200/B300 GPUs Initial B200 shipment completed and fully contracted 50MW Horizon 1 liquid-cooled AI data center on track for Q4’25 Mackenzie fiber upgrade complete, further enhancing our ability to support continued growth of AI Cloud beyond Prince George 1,400MW Sweetwater 1 civil and electrical works continuingKey Metrics Jul 25 Jun 25Bitcoin Mining    Average operating hashrate 45.4 EH/s 41.1 EH/sBitcoin mined4 728 BTC 620 BTCRevenue per Bitcoin mined $114,891 $105,730Net electricity cost per Bitcoin mined2 ($27,976) ($26,259)Revenue $83.6m $65.5mNet...

Continue reading

Stack Capital Group Inc. Reports Q2-2025 Financial Results

TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) — Stack Capital Group Inc., (“Stack Capital” or the “Company”) (TSX:STCK; TSX:STCK.WT.A) today announced its financial results for the quarter ended June 30, 2025. Stack Capital reports all amounts in Canadian Dollars unless otherwise stated. Company Commentary:As at June 30, 2025, Book Value per Share (BVpS) of the Company was $14.34, compared with $12.06 as at March 31, 2025. Stack Capital had its first portfolio investment, CoreWeave (an AI hyper-scaler), go public on March 28, 2025, an exciting milestone for both the Company and CoreWeave. As of June 30, 2025, the Company marked up its investment in CoreWeave by US$25.7 million to reflect its closing price of US$163.06. During Q2-2025, The Company invested an additional US$3M into SpaceX. Following the quarter-end, SpaceX’s valuation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.